Clinical Relevance of CTCs in Primary and Metastatic Breast Cancer



September 13, 2013

The detection of circulating tumor cells in the blood (CTCs) is a common phenomenon seen in 10-20% of primary breast cancer patients. Recent studies have shown a prognostic potential of CTC in both primary and metastatic setting. The evaluation of CTC may become one of the crucial markers for prediction of survival and therapy monitoring.

Flow Chemistry

Keep up to date with all your favourite videos and channels.

Get personalised notifications on new releases and channel content by subscribing to the LabTube eNewsletter.